Amedis-UE
Amedis-UE AG is a Swiss pharmaceutical logistics company that supplies medicines and paramedical products to pharmacies and pharmaceutical industry partners. In January 2025 it merged with Voigt AG and Voigt Industrie Service AG to form Avosano Holding AG.
- Company typePrivate
- Founded2002
- HeadquartersAarau, Switzerland
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Amedis-UE does
Amedis-UE AG is a Swiss pharmaceutical company operating in the healthcare distribution sector, supplying pharmacies, drugstores, and paramedical product channels. It was founded in 2002 and operates within the Swiss domestic market, with its primary sites now anchored at Niederbipp, Puidoux, and Romanshorn following the January 2025 consolidation.
In January 2025, Amedis-UE AG was combined with Voigt AG and Voigt Industrie Service AG to form the Avosano Group under Avosano Holding AG. The resulting group is structured around two operating entities: Avosano AG, which handles pharmaceutical wholesale as the link between manufacturers and specialist retail pharmacies (delivering within a 2-hour window via state-of-the-art logistics centers), and Avosano Industrie Service AG, which provides prewholesale supply chain and market access services to pharmaceutical industrial partners. The go-to-market is sales-led, executed via a field "Aussendienst" team servicing specialist retailers and industrial partners across Switzerland.
Revenue mechanics are split between transaction-based wholesale distribution (margin on the physical distribution of medicines) and service-fee prewholesale arrangements with industrial partners (fees for logistics and market access solutions). The product surface contains no disclosed technology stack, software platform, API, or AI components in the source material; the moat is operational (logistics) and regulatory (Swiss pharmaceutical distribution licensing) rather than technology-led. Marketing is institutional and B2B, executed primarily through a multilingual corporate website (avosano.ch) covering German, French, and English.
Amedis-UE firmographics
Firmographics- Name
- Amedis-UE
- Legal name
- Amedis-UE AG
- Website
- https://amedis.ch
- Company type
- Private
- Founded year
- 2002
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Amedis-UE AG is a Swiss pharmaceutical logistics company that supplies medicines and paramedical products to pharmacies and pharmaceutical industry partners. In January 2025 it merged with Voigt AG and Voigt Industrie Service AG to form Avosano Holding AG.
- Ownership category
- akta.pro rank
Amedis-UE industry classification
Industry- Product category
- Pharmaceutical Wholesale and Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)
Keywords
Where Amedis-UE is headquartered
LocationHeadquarters
- HQ city
- Aarau
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
Amedis-UE business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Pharmaceutical Wholesale: Avosano AG acts as a pharmaceutical wholesaler, supplying medicines from the pharmaceutical industry to specialist trade (retailers). Revenue is generated through the margin earned on the distribution of pharmaceutical products, facilitated by state-of-the-art logistics centers and a flexible delivery structure capable of supplying customers within 2 hours.
- Prewholesale Services: Avosano Industrie Service AG operates as a prewholesale specialist, providing supply chain and market access services to industrial pharmaceutical partners and specialist retailers. Revenue is derived from service fees for prewholesale logistics, market distribution, and tailored solutions for industrial partners.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels1 record
Amedis-UE product offering
Product offeringCore offering
Amedis-UE AG was a Swiss pharmaceutical distribution company that supplied medicines from pharmaceutical manufacturers to specialist retail pharmacies (pharmacies, drugstores) and provided prewholesale services including market access and supply chain management to industrial pharmaceutical partners. Following the January 2025 consolidation into the Avosano Group, the operations continue through Avosano AG (wholesale to specialist trade) and Avosano Industrie Service AG (prewholesale for industrial partners), leveraging state-of-the-art logistics centers with 2-hour delivery capability across three Swiss sites.
Product overview
The Avosano Group (founded January 2025 by combining Amedis-UE AG, Voigt AG, and Voigt Industrie Service AG) operates as a single unified pharmaceutical supply chain services company with two distinct divisions: Avosano AG handles pharmaceutical wholesale distribution to specialist retailers, while Avosano Industrie Service AG provides prewholesale services for industrial market access. Both divisions share state-of-the-art logistics infrastructure and a flexible 2-hour delivery structure across Switzerland.
Differentiator
Problem solved
Functional benefit
Products and services
- Avosano AG – Pharmaceutical Wholesale Pharmaceutical wholesale business that serves as the link between the pharmaceutical industry and specialist retail trade, ensuring the supply of medicines to consumers through state-of-the-art logistics centers and a flexible delivery structure capable of 2-hour supply. Targeted at specialist pharmacies and healthcare retailers in Switzerland.
- Avosano Industrie Service AG – Prewholesale Services Prewholesale services provider enabling industrial pharmaceutical partners to access the Swiss market efficiently and securely, offering specialist retailers a wide range of high-quality, reliable, and efficient supply chain services. Targeted at pharmaceutical manufacturers and industrial partners.
Quantifiable outcome
- Pharmaceutical supply within 2 hours to customers from logistics centers
Companies that use Amedis-UE
Customer profileSegments2 records
Ideal customer profiles2 records
Amedis-UE technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Amedis-UE partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Amedis-UE AGcoreAmedis-UE AG was one of three founding entities that merged in January 2025 to form the Avosano Group. It contributed resources, know-how, infrastructure, and experience to create the combined pharmaceutical logistics holding. Avosano Group states it was 'founded in January 2025 by combining the resources, know-how, infrastructure and experience of Amedis-UE AG, Voigt AG and Voigt Industrie Service AG.' Amedis-UE AG is now part of the consolidated Avosano Group structure.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Amedis-UE competitors and assessment
Company assessmentBroad incumbents
- Celesio / McKesson Europe: European pharmaceutical distribution arm of McKesson, operating through Lloyds Pharmacy and the Galexis network. Provides a direct upstream benchmark for the Avosano Group's wholesale-plus-prewholesale service model.
- Noweda eG: German cooperative pharmaceutical wholesaler with strong retail-pharmacy focus, similar to Avosano's specialist retail trade customer base. Provides a useful benchmark on cost-to-serve and logistics economics in pharma wholesale.
- Phoenix Group: Europe's largest pharmaceutical wholesale group, operating across 29 countries including neighboring Germany. Phoenix provides the most relevant pan-European scale benchmark and competes for industrial pharma customers that also use Swiss distributors.
- Alliance Healthcare (Walgreens Boots Alliance): Pan-European pharma wholesale and distribution business owned by Walgreens Boots Alliance, parent of Galexis. Highly comparable in service mix (wholesale and prewholesale) and in serving specialist retail customers across Europe.
- Sanacorp eG: German pharmaceutical cooperative wholesaler serving independent pharmacies. Comparable business model to Avosano's specialist-retail wholesale, although operating only in Germany and not directly competing in Switzerland.
Direct peers
- Hänseler AG: Swiss pharmaceutical wholesaler with a long history of supplying medicines to Swiss pharmacies and hospitals. Highly comparable in geography, customer base and product mix to the Amedis-UE/Voigt businesses that now sit within Avosano.
- Galexis AG: Galexis is Switzerland's largest pharmaceutical wholesaler and the principal direct competitor to Avosano AG, supplying medicines to Swiss pharmacies with nationwide distribution. Both operate in Swiss pharma wholesale to specialist retail, making them the closest functional comp.
Regional players
- Dr. A. & L. Schmidgall GmbH & Co KG: Austrian pharmaceutical wholesaler serving the Austrian and parts of the broader DACH region. Comparable product mix and customer base to Avosano, though operating in a different (DACH but not Swiss) national market.
- Amino AG: Swiss logistics and distribution company with pharmaceutical wholesale activities. Comparable Swiss-based pharma logistics focus, though with a broader portfolio including cosmetics and consumer healthcare distribution.
Others
- Voigt AG / Voigt Industrie Service AG: Sister companies combined with Amedis-UE AG in January 2025 to form the Avosano Group. Voigt AG was a specialist pharma wholesaler and Voigt Industrie Service AG a prewholesale/industrial service provider with overlapping services and customer base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Amedis-UE social profiles
Digital presenceAmedis-UE financial estimates
Financial estimateRevenue estimate
Valuation estimate
Amedis-UE leadership team
Management profileNumber of profiles
Profiles1 record
Amedis-UE funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Amedis-UE M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Amedis-UE
What does Amedis-UE do?
Amedis-UE AG was a Swiss pharmaceutical distribution company that supplied medicines from pharmaceutical manufacturers to specialist retail pharmacies (pharmacies, drugstores) and provided prewholesale services including market access and supply chain management to industrial pharmaceutical partners. Following the January 2025 consolidation into the Avosano Group, the operations continue through Avosano AG (wholesale to specialist trade) and Avosano Industrie Service AG (prewholesale for industrial partners), leveraging state-of-the-art logistics centers with 2-hour delivery capability across three Swiss sites.
Is Amedis-UE a public or private company?
Amedis-UE is a private company. It is classified as corporate owned and is currently acquired.
When was Amedis-UE founded?
Amedis-UE was founded in 2002. It employs 251 to 500 people.
Where is Amedis-UE based?
Amedis-UE is headquartered in Aarau, Switzerland, in the Europe region.
How does Amedis-UE make money?
Two revenue lines are on record. Pharmaceutical Wholesale is the primary driver. The others are prewholesale Services.
Who are Amedis-UE's main competitors?
Broad incumbents on record are Celesio / McKesson Europe, Noweda eG, Phoenix Group, Alliance Healthcare (Walgreens Boots Alliance) and Sanacorp eG. Direct peers are Hänseler AG and Galexis AG. Regional players are Dr. A. & L. Schmidgall GmbH & Co KG and Amino AG. Voigt AG / Voigt Industrie Service AG is listed as an others.
Does Amedis-UE have an API?
No public API is recorded for Amedis-UE.
What industry is Amedis-UE in?
Amedis-UE's product category is Pharmaceutical Wholesale and Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution. Its NAICS code is 424210 and its SIC code is 5047.